Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APIXABAN vs APREPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

APIXABAN vs APREPITANT: Safety Overview

Metric APIXABAN APREPITANT
Total FAERS Reports 159,846 5,620
Deaths Reported 27,970 1,195
Death Rate 17.5% 21.3%
Hospitalizations 42,651 2,917
Average Patient Age 74.5 yrs 52.8 yrs
% Female Patients 51.9% 70.9%
FDA Approval Date Apr 17, 2025 Dec 17, 2015
Manufacturer A-S Medication Solutions Heron Therapeutics, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription